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OBJECTIVES The goal of our study was to examine how age and gender affect the use of coronary
angiography and the intensity of cardiac follow-up care within the first year after acute
myocardial infarction (AMI). Another objective was to evaluate the association of age, gender
and treatment intensity with five-year survival after AMI.
BACKGROUND Utilization rates of specialized cardiac services inversely correlate with age. Gender-specific
practice patterns may also vary with age in a manner similar to known age–gender survival
differences after AMI.
METHODS Using linked population-based administrative data, we examined the association of age and
gender with treatment intensity and long-term survival among 25,697 patients hospitalized
with AMI in Ontario between April 1, 1992, and December 31, 1993. A Cox proportional
hazards model was used to adjust for socioeconomic status, illness severity, attending
physician specialty and admitting hospital characteristics.
RESULTS After adjusting for baseline differences, the relative rates of angiography and follow-up
specialist care for women relative to men, respectively, fell 17.5% (95% confidence interval
[CI], 13.6 to 21.3, p  0.001) and 10.2% (95% CI, 7.1 to 13.2, p  0.001) for every 10-year
increase in age. Conversely, long-term AMI survival rates in women relative to men improved
with increasing age, such that the relative survival in women rose 14.2% (95% CI, 10.1 to
17.5, p  0.001) for every 10-year age increase.
CONCLUSIONS Gender differences in the intensity of invasive testing and follow-up care are strongly
age-specific. While care becomes progressively less aggressive among older women relative to
men, survival advantages track in the opposite direction, with older women clearly favored.
These findings suggest that biology is likely to remain the main determinant of long-term
survival after AMI for women. (J Am Coll Cardiol 2002;39:1909–16) © 2002 by the
American College of Cardiology Foundation
Gender differences in cardiovascular care after acute myo-
cardial infarction (AMI) have been studied in a number of
settings (1–6). Variations in the use of evidence-based
therapies between men and women are generally smaller
and less consistent than those associated with the use of
more discretionary interventions where the benefits are less
clear (2,3,7). Studies of gender-treatment differences are
also confounded by age effects. Treatment selection and
referral behaviors are influenced by age (2,8–10); therefore,
the delayed onset of coronary disease in women probably
contributes to the observed variations in clinical decision-
making. Indeed, the relationship between gender and dis-
ease severity may also vary by age. For example, in order for
coronary disease to occur in younger women, the disease
must be particularly aggressive or driven by the presence of
multiple risk factors (11,12). Physicians may accordingly
adopt more aggressive referral patterns in younger women.
While investigators have routinely studied the relationship
between gender and treatments within age-specific strata,
few have examined how gender-specific treatments differ
across all ages.
A parallel concern is the fact that many studies have
demonstrated an age–gender mortality interaction for AMI
such that younger, but not older, women have higher
mortality rates when compared with men of similar ages
(13–15). Given age–gender differences in treatment, one
might reasonably ask: to what extent do gender-specific
differences in outcomes after AMI reflect biology as op-
posed to age/gender bias?
The objectives of this study were to examine whether
gender-related differences in the use of specialized cardiac
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services vary according to age and, if so, to what extent such
differences in service intensity are associated with variations in
longer-term mortality between men and women after AMI.
METHODS
Patient selection. We collected information from the On-
tario Myocardial Infarction Database (OMID), which links
together a variety of administrative databases in Ontario.
Complete details regarding the construction, eligibility and
accuracy of OMID have been previously described (16–18).
Using the Canadian Institute for Health Information
(CIHI) hospital discharge database, we examined all On-
tarians admitted with a most responsible diagnosis of AMI
(International Classification of Diseases, 9th Revision,
Clinical Modification [ICD-9-CM] code 410) between
April 1, 1992 to December 31, 1993.
Baseline sociodemographic, clinical and hospital charac-
teristics. Baseline patient characteristics including age,
gender, socioeconomic status and disease severity were
obtained from CIHI discharge abstracts of the index AMI
admission. Socioeconomic data were obtained using neigh-
borhood income level obtained from 1991 official Canadian
census data. To control for variations in patient severity of
illness on admission, we used the Ontario AMI mortality
prediction rule for 30-day mortality (18). The variables in
this model include age, gender, cardiac severity (e.g., con-
gestive heart failure, cardiogenic shock, arrhythmias) and
comorbid status (e.g., diabetes mellitus, stroke, acute and
chronic renal disease and malignancy) as derived from the
ICD-9 codes present in the 15 secondary diagnostic fields of
the CIHI database. The predictive models showed good
predictive power, with areas under the receiver operating
characteristics cure of 0.78 and 0.79 for 30-day and for
one-year mortality, respectively. The derivation and valida-
tion of the Ontario AMI prediction rule is described
elsewhere (18,19). Excluding age and gender from the
mortality prediction rule did not significantly alter our
results.
Available evidence suggests that AMI processes of care
are also influenced by other physician and hospital charac-
teristics. These include attending physician specialty (20),
hospital volumes (based on the annual number of patients
admitted to the myocardial infarction facility) (18,21), the
presence or absence of on-site procedural characteristics at
the admitting hospital (22), hospital teaching status (17)
and geographical proximity to the nearest tertiary facility
(from latitude and longitude coordinates, “as the crow flies”)
(23). Attending physician specialty and physician specialty
visits were identified using hospital discharge abstracts and
Ontario Health Insurance Plan claims data, respectively.
During the study period, there were 197 acute care hospitals
in Ontario. Three rural isolated hospitals were excluded
from the analysis given that census data suppress informa-
tion needed to obtain socioeconomic status in isolated rural
communities. Four institutions had on-site angiography-
only facilities comprising 3.5% of the sample population and
were also excluded from the analysis because of small sample
size.
Specialized cardiac care and outcome. Coronary angiog-
raphy and out-patient follow-up care served as the two
process indicators of intensity of service, while mortality was
the sole outcome examined in this study. Coronary angiog-
raphy was examined within the first six months of the index
AMI, in order to allow for post-MI risk stratification and
lengthy waiting list delays for coronary angiography in
Ontario at that time (23). Mortality was assessed at five
years after MI to allow for a sufficient opportunity to observe
long-term prognostic benefits attributable to procedures if
such were to exist (24).
Statistical analysis. We began by subdividing our cohort
into four pre-specified age groups (ages 20 to 49, 50 to 64,
65 to 74 and 75) in order to examine baseline character-
istics and crude outcomes between men and women. The
age-specific breakdown classification used in this study has
been previously incorporated by our group in other studies
(23). Unadjusted gender differences were examined using
chi-square tests of proportions.
We then examined age as a continuous variable, evaluat-
ing age-specific gender effects applying an age–gender
interaction term. Multivariate analyses using Cox propor-
tional hazard models were developed to examine the asso-
ciation between age–gender, process (coronary angiography,
post-discharge follow-up care) and outcome (mortality)
after adjusting for age, socioeconomic status, illness severity
(probability of 30-day mortality), attending physician spe-
cialty, and the four hospital characteristics described above.
Formal diagnostic testing for collinearity across hospital-
and/or physician-level variables did not reveal any variance
inflation factor to be 5.0. Therefore, collinearity was not a
significant issue for this analysis (i.e., the maximum Vari-
ance Inflation Factor across explanatory variables for the
190 hospitals was 2.6) (25).
All models were derived in a similar fashion. Patient
characteristics (age, gender, socioeconomic status, illness
severity) were forced into the statistical model, while phy-
sician and hospital characteristics whose variables were
significant at a p value of 0.2 in univariate fashion were
selected using backward stepwise regression techniques by
comparing the 2 log likelihoods ratio test of the Cox
proportional hazards. Because early mortality results in less
opportunity for patients to receive treatments or specialty
follow-up care, death was the main censoring variable.
Adjusted survival rates were examined among patients who
received coronary angiography or post-discharge follow-up
Abbreviations and Acronyms
AMI  acute myocardial infarction
CIHI  Canadian Institute for Health Information
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OMID  Ontario Myocardial Infarction Database
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care and among those who received neither. To examine the
robustness of our analyses, a parametric survival model that
did not assume proportional hazards was fit to our data;
similar results were obtained.
Statistical significance was defined as p  0.05 for all
analyses. SAS version 8.2 statistical software was used for all
statistical analyses.
RESULTS
Baseline. The cohort consisted of 25,697 patients (16,756
men, 8,941 women) and had a mean age of 66.6 years (64.1
vs. 71.2 for men and women, respectively, p  0.001).
While the distribution of age was more homogenous within
the four pre-specified age groups, women were still, on
average, significantly older than men by 0.4 years, 0.6 years
and 1.1 years in the 50 to 64 year, 65 to 74 year and 75
year age groups, respectively (p  0.001 for each). The
utilization rates of six-month coronary angiography and
one-year cardiology follow-up were 23.6% and 38.7%,
respectively; 40.7% of the cohort died within five years after
AMI.
Table 1 demonstrates the unadjusted odds ratios in
women relative to men for each baseline characteristic across
the four pre-specified patient subgroups. Among the
younger age categories, women were significantly poorer
and sicker than were men. However, gender differences in
socioeconomic status and illness severity markedly narrowed
among elderly age groups. While the distribution of hospital
services was similar among women and men across all age
groups, elderly women were significantly more likely to be
seen by general practitioners than were elderly men.
Unadjusted rates of specialty care and outcomes. Table 2
illustrates that the unadjusted odds ratio of receiving coro-
nary angiography and cardiac follow-up specialty care after
discharge in women relative to men decreased with advanc-
ing age. The likelihood that women, compared with men,
were not followed up by any specialist (either a cardiologist
or an internist) grew with increasing age. Despite the
inverse relationship between age and treatment aggressive-
ness in women relative to men, crude five-year mortality
rates in women relative to men decreased with advancing
age.
Adjusted rates of specialty care and outcomes. Figure 1
illustrates the age/gender-specific rates of coronary angiog-
Table 1. Unadjusted OR ( 95% Confidence Limits) for Baseline Characteristics in Women Relative to Men According to Age-
Group Categories for Patients Hospitalized With AMI in Ontario Between April 1, 1992, and December 31, 1993
20–49 yrs
(n  473 Women)
(n  2,483 Men)
50–64 yrs
(n  1,817 Women)
(n  5,699 Men)
65–74 yrs
(n  2,719 Women)
(n  4,770 Men)
75 yrs
(n  3,932 Women)
(n  3,804 Men)
OR p Value OR p Value OR p Value OR p Value
Demographic
Highest socioeconomic quartile 0.70 (0.54–0.89) 0.003 0.69 (0.60–0.78)  0.001 0.88 (0.78–0.98) 0.02 0.91 (0.82–1.01) 0.07
Clinical
Congestive heart failure 2.27 (1.52–3.39) 0.001 1.44 (1.22–1.69)  0.001 1.13 (1.16–1.46)  0.001 1.10 (1.00–1.21) 0.05
Pulmonary edema 0.58 (0.07–4.61) 0.60 2.11 (1.28–3.47) 0.002 0.78 (0.52–1.18) 0.24 1.10 (0.82–1.48) 0.51
Diabetes with complications 3.07 (1.65–5.72)  0.001 2.85 (2.02–4.01)  0.001 2.09 (1.59–2.92)  0.001 1.33 (0.86–2.06) 0.20
Shock 2.18 (0.90–5.28) 0.08 2.11 (1.46–3.03)  0.001 1.17 (0.88–1.54) 0.28 1.04 (0.82–1.34) 0.72
Malignancy 1.49 (0.70–3.13) 0.30 1.28 (0.93–1.74) 0.12 0.84 (0.66–1.09) 0.19 0.66 (0.53–0.82) 0.001
Stroke 1.37 (0.59–3.16) 0.46 1.46 (1.06–2.02) 0.02 1.03 (0.80–1.31) 0.84 0.96 (0.79–1.15) 0.64
Cardiac dysrhythmias 1.28 (0.89–1.84) 0.18 0.88 (0.74–1.06) 0.18 0.78 (0.68–0.89)  0.001 0.88 (0.78–0.99) 0.03
Acute renal insufficiency 1.75 (0.18–16.9) 0.62 1.35 (0.62–2.94) 0.46 0.97 (0.66–1.43) 0.88 0.69 (0.52–0.91) 0.008
Chronic renal insufficiency 2.65 (1.13–6.23) 0.02 1.55 (0.95–2.50) 0.07 1.26 (0.91–1.73) 0.16 0.70 (0.53–0.92) 0.01
Highest predicted probability of
30-day mortality quartile
1.86 (1.45–2.38)  0.001 1.29 (1.15–1.45)  0.001 1.02 (0.90–1.17) 0.74 0.92 (0.83–1.02) 0.12
Attending physician
Cardiologist 0.85 (0.68–1.06) 0.16 0.91 (0.80–1.02) 0.11 0.86 (0.76–0.96) 0.007 0.96 (0.86–1.08) 0.51
Internal medicine 0.96 (0.79–1.18) 0.73 1.01 (0.91–1.13) 0.81 0.98 (0.89–1.08) 0.65 0.85 (0.78–0.93)  0.001
General practice 1.24 (0.98–1.56) 0.07 1.09 (0.96–1.24) 0.17 1.20 (1.07–1.33) 0.001 1.24 (1.13–1.36)  0.001
Hospital
On-site revascularization
facilities
1.02 (0.75–1.40) 0.89 0.93 (0.79–1.10) 0.38 0.92 (0.79–1.07) 0.28 0.99 (0.86–1.15) 0.93
Large volume hospitals
(100 AMI cases/yr)
0.91 (0.73–1.15) 0.43 0.92 (0.82–1.05) 0.21 1.01 (0.90–1.12) 0.91 0.95 (0.86–1.05) 0.33
Small volume hospitals
(30 AMI cases/yr)
1.72 (1.15–2.56) 0.007 0.96 (0.76–1.21) 0.72 0.82 (0.67–1.00) 0.05 1.01 (0.86–1.19) 0.90
Close (10 km) proximity to a
revascularization center
0.94 (0.76–1.17) 0.58 1.01 (0.90–1.13) 0.89 0.93 (0.84–1.03) 0.18 1.04 (0.94–1.14) 0.47
Far (50 km) proximity to a
revascularization center
1.30 (1.06–1.59) 0.01 1.10 (0.99–1.22) 0.08 1.00 (0.91–1.11) 0.92 0.95 (0.87–1.04) 0.29
Teaching hospital 1.10 (0.85–1.42) 0.46 0.97 (0.85–1.11) 0.67 0.92 (0.82–1.04) 0.20 1.05 (0.94–1.18) 0.40
AMI  acute myocardial infarction; OR  odds ratio.
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raphy and post-discharge follow-up care after adjusting for
baseline case-mix, attending physician and admitting hos-
pital characteristics. For each of the three variables exam-
ined, younger women were treated more aggressively than
younger men, while older women were treated less aggres-
sively than older men. For every 10 years of increasing age,
the relative decreases in the risk ratios for coronary angiog-
raphy and cardiology specialty follow-up in women relative
to men were 17.5% (95% confidence interval, 13.6 to 21.3,
p 0.001) and 10.2% (95% confidence interval, 7.1 to 13.2,
p  0.001), respectively. Absolute differences in treatments
across age groups were greater than the absolute differences in
treatments between men and women (Fig. 1). Accordingly,
while a significant age–gender interaction existed, age was a
much stronger predictor of utilization than was gender.
Figure 2 illustrates age/gender-specific survival rates after
adjusting for baseline case-mix, attending physician and
admitting hospital characteristics. Among younger patients,
women had lower five-year adjusted survival rates than men;
among older patients, women had higher five-year survival
rates than men. The interaction between age and gender
was significant. Specifically, for every 10 years of increasing
age, the relative hazard change of death in women as
compared with men decreased by 14.2% (95% confidence
interval, 10.1 to 17.5, p  0.001). Moreover, the relation-
ship between age, gender and mortality was similar between
those who received coronary angiography or cardiac spe-
cialty care and those who did not. Absolute differences in
survival across age groups were greater than the absolute
differences in survival between men and women (Fig. 2).
Accordingly, while the age–gender mortality interaction
was consistent across subgroups, age again was a stronger
predictor of mortality than was gender. In sum, the rela-
tionship between age–gender and process of care factors was
discordant to that between age–gender and outcomes.
Survival differences in women improved with increasing age
despite receiving less aggressive interventions.
DISCUSSION
Our study demonstrates a paradoxical age–gender interac-
tion for long-term treatments and outcomes for patients
hospitalized with AMI in Ontario. The aggressiveness of
physician referrals for coronary angiography and follow-up
specialty care diminished with increasing age, but did so
faster among women than among men after AMI. In
contrast, survival rates in women relative to men improved
with increasing age at presentation.
The age– gender treatment interaction. Many cardiovas-
cular studies have demonstrated less aggressive diagnostic
and management strategies in women relative to men.
Researchers have referred to such differences as a reflection
of a “gender bias” (4,6). Although our results do support the
presence of gender-specific treatment differences for two key
markers of service intensity, the association was complex
and age-dependent. Most studies have focused on gender as
an isolated entity when determining its relationship to
treatments, ignoring its interaction with other biological
factors. The age-dependent effects of gender may account
for inconsistencies in findings across studies examining for
gender variations in treatments and outcomes after AMI
(1–6,10,13–15,26–29). Although these studies have rou-
tinely adjusted for differences in age, few have examined
whether gender effects differ according to the age at which
patients initially present with AMI (13–15). Our results
would suggest that researchers and clinicians who draw
inferences on “overall” gender-treatment effects must do so
with caution. Moreover, given that age was a more impor-
tant determinant of process and outcomes of care than
gender, treatment differences in men and women may
largely reflect an issue of “age bias” rather than “gender
bias,” especially when considering that women present with
AMI at considerably older ages than do men.
The higher rate of interventions among younger women
observed in this study may be appropriate given their higher
relative rates of congestive heart failure, shock and diabetes
as compared with similarly aged men. While illness severity
appears to be the driving determinant of physician aggres-
siveness among patients in younger age groups, advancing
age leads to reduced intensity of care, particularly among
women. A conservative approach to treatment among older
women may reflect the perception that elderly women incur
Table 2. Unadjusted OR ( 95% Confidence Limits) for Coronary Angiography, Specialty Follow-Up Care and Mortality in
Women Relative to Men According to Age-group Categories for Patients Hospitalized With AMI in Ontario Between April 1,
1992, and December 31, 1993
20–49 yrs 50–64 yrs 65–74 yrs 75 yrs
OR p Value OR p Value OR p Value OR p Value
Coronary angiography within six months
after MI
0.96 (0.79–1.17) 0.67 0.82 (0.73–0.92)  0.001 0.73 (0.65–0.83)  0.001 0.60 (0.49–0.74)  0.001
Cardiology follow-up within 12 months
after hospitalization
1.09 (0.89–1.33) 0.40 0.87 (0.77–0.97) 0.01 0.88 (0.79–0.99) 0.03 0.74 (0.65–0.84)  0.001
General practitioner-only or no physician
follow-up within 12 months after
hospitalization
0.92 (0.61–1.39) 0.67 1.16 (0.97–1.41) 0.11 1.28 (1.12–1.47)  0.001 1.52 (1.37–1.69)  0.001
Five-year mortality 1.68 (1.24–2.26)  0.001 1.34 (1.18–1.52) 0.18 1.07 (0.97–1.17) 0.18 0.85 (0.77–0.93)  0.001
MI  myocardial infarction; OR  odds ratio.
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Figure 1. Adjusted rates of treatments and follow-up care according to age at acute myocardial infarction (AMI) presentation. (A) Adjusted risk ratios of
coronary angiography by six months after AMI according to age. Adjusted risk ratios  95% confidence intervals for angiography by six months after
myocardial infarction (MI) for a typical male and female patient (average median neighborhood income and predicted probability of 30-day mortality who
is admitted to an internist at a non-tertiary hospital). P value for the age–gender interaction, p  0.001. (B) Adjusted risk ratios of follow-up by a
cardiologist by one-year after AMI according to age. Adjusted risk ratios  95% confidence intervals for cardiology follow-up care by one year after MI
for a typical male and female patient (average median neighborhood income and predicted probability of 30-day mortality who is admitted to an internist
at a non-tertiary hospital). P value for the age–gender interaction, p 0.001. (C) Adjusted risk ratios of general practitioner-only or no physician follow-up
by one year after AMI according to age. Adjusted risk ratios  95% confidence intervals for general practitioner-only or no physician follow-up care by
one year after MI for a typical male and female patient (average median neighborhood income and predicted probability of 30-day mortality who is admitted
to an internist at a non-tertiary hospital). P value for the age–gender interaction, p  0.001. Solid diamond  men; open square  women.
1913JACC Vol. 39, No. 12, 2002 Alter et al.
June 19, 2002:1909–16 Gender, Practice Patterns and Outcomes After AMI
greater risk but fewer benefits when subjected to cardiac
interventions compared with elderly men (1,2,7,10,30–32).
Perceptions of risk-benefit tradeoffs may also reflect
service supply or system capacity. When confronted with
limited capacity for specialized cardiac services, physicians
become more stringent when selecting patients for discre-
tionary interventions (33). Thus, any age or gender effects
on physician decision-making might be more evident in a
jurisdiction such as Ontario given the associated limited
availability of coronary angiography and specialty cardiac
physicians (23).
The age– gender mortality interaction. The age–gender
mortality interaction noted in our study confirms the find-
ings of at least one recent study that examined 8,277
patients hospitalized in Worcester, Massachusetts, between
1975 and 1995 (14). Despite differences in the U.S. and
Canadian health care systems and variation in time periods
examined between the two cohorts, the relative changes in
magnitude for mortality with increasing age in women
relative to men were strikingly similar between the two
cohorts (decreases of 15.4% and 14.2% in the relative
hazards of death for every 10-year increase in age among
U.S. and Canadian cohorts, respectively).
In our study, the relationship between age–gender and
mortality bore no relation to that between age–gender and
treatments after AMI. Other studies examining gender
variations in the use of in-hospital services have also failed
to account for outcome differences between men and
women after AMI (3,15). One recent population-based
study has suggested that the age–gender mortality interac-
tion among patients with AMI may be attributable to
selection bias or a survivor effect arising from gender
differences in the rates of out-of-hospital deaths before
AMI presentation (34). Whether or not that finding can be
confirmed, the interactions demonstrated here between age,
gender, service patterns and outcomes support the hypoth-
esis that intrinsic biological and/or psychosocial factors are
more likely to explain gender-related outcome differences
after MI than gender bias in the care of post-AMI patients
(35–39).
Study limitations. Our study focused on only two process-
of-care measures. However, several studies have demon-
strated a positive relationship between specialized cardiac
service intensity and outcomes after AMI (17,40,41). Ac-
cordingly, we believe these measures serve as a reasonable
test case for a relationship between process and outcomes of
care. Second, our data lacked clinical detail. Accordingly, we
had no information directly indicating the initial infarct
Figure 2. Adjusted five-year survival rates according to age at acute myocardial infarction (MI) presentation. Adjusted five-year hazards of death for a typical
male and female patient (average median neighborhood income and predicted probability of 30-day mortality who is admitted to an internist at a
non-tertiary hospital). P value for the age–gender interaction, p  0.001. Solid diamond  men; open square  women.
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location, hemodynamic status and degree of impairment of
left ventricular function. While we did adjust for a number
of clinical factors, it is possible that the inclusion of
additional clinical variables might have altered our results.
Third, we examined patients admitted to Ontario hospitals
between 1992 and 1993. We did so to ensure a minimum of
five-year follow-up on all patients, but it is uncertain
whether the observed practice patterns would be the same
today. Finally, without studying the perspectives of physi-
cians, it is not possible to explain the observed interaction
between age and gender in determining treatments after
AMI. Nonetheless, these limitations must be traded off
against the comprehensiveness of a very large population-
based AMI cohort that is highly representative of the
Canadian population.
Conclusions. Gender differences in treatments and out-
comes after AMI are highly complex phenomena. The
relationships between gender, patterns of practice and long-
term outcomes vary according to age. Gender differences in
treatments strongly correlated with age differences of the
relevant patient subgroups. Long-term outcome differences
between men and women are more likely explained by
intrinsic biological factors rather than by variations in
processes of care after AMI.
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